Therapeutic Asset Ratings
6,308 results matching 1 filter
91,564 assets · 7,904 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Low Dose Lx2006
Extrinsic Cardiomyopathy
Lexeo Therapeutics
P1/2
CCC
(48)
Lu Ag13909
Congenital Adrenal Hyperplasia
H. Lundbeck A/S
P1/2
CCC
(48)
Lurbinectedin
Ewing Sarcoma
Jazz Pharmaceuticals
P1/2
CCC
(48)
Lutetium-177-Dotaga-Iac
Breast Cancer
Advanced Imaging Projects, LLC
P1/2
CCC
(48)
Lutetium (<Sup>177</Sup>Lu) Zadavotide Guraxetan
Nonpapillary Renal Cell Carcinoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
P1/2
CCC
(48)
ly3884961
Gaucher Disease Type II
Prevail Therapeutics
P1/2
CCC
(48)
Ly-M001
Gaucher Disease Type I
Lingyi Biotech Co., Ltd.
P1/2
CCC
(48)
m701 pleural infusion
Pleural Disorder
Wuhan YZY Biopharma Co., Ltd.
P1/2
CCC
(48)
m701 pleural infusion
Non-Small Cell Lung Carcinoma
Wuhan YZY Biopharma Co., Ltd.
P1/2
CCC
(48)
Mannitol
Breast Cancer
National Taiwan University Hospital
P1/2
CCC
(48)
Max-40279-01
Acute Myeloid Leukemia
Maxinovel Pty., Ltd.
P1/2
CCC
(48)
Max-40279-01: /
Metastatic Neoplasm
Maxinovel Pty., Ltd.
P1/2
CCC
(48)
mb-106
Follicular Lymphoma
Mustang Bio
P1/2
CCC
(48)
mb-106
Mantle Cell Lymphoma
Mustang Bio
P1/2
CCC
(48)
mb-106
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Mustang Bio
P1/2
CCC
(48)
mb-106
Waldenstrom Macroglobulinemia
Mustang Bio
P1/2
CCC
(48)
Mdna11
Basal Cell Carcinoma
Medicenna Therapeutics, Inc.
P1/2
CCC
(48)
Mdna11
Endometrial Carcinoma
Medicenna Therapeutics, Inc.
P1/2
CCC
(48)
Mdna11
Ovarian Carcinoma
Medicenna Therapeutics, Inc.
P1/2
CCC
(48)
Mdna11
Gastroesophageal Junction Adenocarcinoma
Medicenna Therapeutics, Inc.
P1/2
CCC
(48)
Mdna11
Virus Associated Tumor
Medicenna Therapeutics, Inc.
P1/2
CCC
(48)
mdx2003
Follicular Lymphoma
ModeX Therapeutics, An OPKO Health Company
P1/2
CCC
(48)
mdx2003
Primary Mediastinal Large B-Cell Lymphoma
ModeX Therapeutics, An OPKO Health Company
P1/2
CCC
(48)
mdx2003
Waldenstrom Macroglobulinemia
ModeX Therapeutics, An OPKO Health Company
P1/2
CCC
(48)
Mercaptopurine Anhydrous
Myelodysplastic Syndrome
Haukeland University Hospital
P1/2
CCC
(48)
Showing 1451 to 1475 of 6,308 assets
Previous
Page 59 of 253
Next